… Several biomarkers have shown promise, but a definitive diagnostic test is yet to be found. …
Notably, all female subjects in this study were taking estrogen-dominant oral contraceptives; …

… that the sex and gender differences in many neurological … a lower risk of ischemic stroke
recurrence in subjects who … clinical presentation, diagnostic evaluation, treatment options, …

… T2DM diagnosis was made according to the ADA criteria (… We also found gender differences
in patterns of cognitive test … However, at least in our cohort, circulating leptin, although …

… for fluid biomarkers in improving diagnostic accuracy, patient … -1), and lower levels of IL-1
receptor antagonist and leptin, in AD … markers of AD in the ADNI cohort suggest that vascular …

… CDR, gender, and age; the position of the CSF and plasma … to predict BBB impairment with
a diagnostic accuracy of 91.38… , however, only 16 subjects had a BBB impairment, ie, a CSF/…

… mild cognitive impairment (MCI), can improve diagnostic … 6% of subjects in the treatment
group developing meningoencephaltis (… ’s Disease Neuroimaging Initiative (ADNI) were used to …

… , in subjects defined as AD cases, cognitive functions such as … Furthermore, leptin levels in
circulation seem to be lower in … Our results show that 24OH levels did not differ in diagnoses …

… all three features is necessary for a definitive diagnosis of AD [1], it … cognitively normal
subjects prior to any therapeutic intervention. While our cross-sectional study suggests that plasma …

Background and objectives Type 2 diabetes mellitus (T2DM) is an important risk factors for
mild cognitive impairment (MCI). Structural magnetic resonance imaging (sMRI) is an …

… obesity and dementia is the gap in gender-inherent differences. It has been postulated that
… Obese subjects also present increased levels of circulating leptin, usually related to leptin …